Actos Canada-Wide National Class Action
Merchant Law Group LLP is pursuing Actos class action litigation against Takeda Pharmaceuticals and Eli Lilly, manufacturers of the DIABETES MEDICATION Actos (pioglitazone), on behalf of affected Canadians, who suffer from Bladder Cancer as a result of taking Actos.
Actos Class Action Lawsuit
Actos is an anti-diabetic drug prescribed to decrease blood sugar levels in patients with type 2 diabetes.
Actos Increases the Risk of Bladder Cancer
In 2012, Health Canada issued a warning that the use of Actos may be linked to bladder cancer. A ten-year observational study found that there may be a 40 percent increased risk of bladder cancer for people who have taken Actos for more than one year.
Are You Eligible for Compensation?
If you’ve taken Actos for more than one year to manage your type 2 diabetes and have since developed bladder cancer, you may be eligable for compensation in the future, if this class action is successful. Compensation might also be available for the family and estate of a deceased person who used Actos.
If you wish to be kept advised of the status of the Actos class action and any resulting compensation program resulting from this litigation in Canada, please provide your contact information to our law firm using the below form. Or email email@example.com with your contact information, for a confidential consultation with one of our Actos lawyers. There is no fee for this consultation.
Other details about the Actos Class Action Lawsuit
Actos was approved for sale in Canada in 2000 to control blood sugar levels in people with Type 2 diabetes.
A 2011 treatment study reported to the FDA a clear link between Actos and increased bladder cancer risk. Health Canada subsequently commenced a year-long review and, in April 2012, following that review, the product monographs of ACTOS were updated to reflect the increased risk of bladder cancer.
The Start and Spread Of Bladder Cancer
Most bladder cancers start in the inner lining of the bladder, as the cancer grows into or through the other layers in the bladder wall, it becomes more advanced and can be harder to treat and eventually spreading to nearby lymph nodes or other parts of the body.
Symptoms and Signs
Blood in the urine (called hematuria) is commonly the first sign of bladder cancer. Sometimes, there is enough blood to change the color of the urine to orange, pink, or, less often, darker red. Ask a doctor for a urinalysis if you happen to have blood in your urine. Blood can appear with a person without bladder cancer however if blood reappears you have a HIGH risk of having bladder cancer.
Bladder cancer also causes changes in urination such as:
- Having to urinate more frequently
- Pain or burning sensation while urinating
- Feeling the urge to go when bladder isn’t full
- Having troubles urinating or a weak urine stream
Symptoms of advanced bladder cancer
Bladder cancers that have spread to other parts of the body can sometimes cause other symptoms, such as:
- Inability to urinate
- Lower back pains on one side
- Loss of appetite
- Weight loss
- Fatigue or weakness
- Feet swelling
- Back Pain
Many of these symptoms are more likely to be caused by something other than bladder cancer, but it’s very important to visit a doctor to further asses and treat the symptoms.
IF YOU WISH TO JOIN THE CONTACT LIST FOR THIS CLASS ACTION, PLEASE COMPLETE THE BELOW FORM. (Please note, providing your information creates no lawyer-client obligation or financial obligation for you. You are not charged any fee or cost for joining this class action – our law firm will simply paid a contingency fee from the compensation recovered, if this class action is successful.)
Merchant Law Group LLP has 10 offices across Canada, with lawyers practising law in six provinces. Merchant Law Group LLP and Tony Merchant, Q.C. are well known for pursuing class action lawsuits in Canada including litigation regarding Winners/HomeSense, Various Cellular Phone Fees, BCE Dividends, GM Gasket Manifolds, Hip Implants, Lead Paint in Toys (and similar consumer products), Maple Leaf, Celebrex/Bextra, Vioxx, Sony, Residential Schools and various other cases. Tony Merchant, Q.C. is known to be one of Canada’s most active litigators with more than 600 reported cases in leading Caselaw Journals, having argued thousands of cases before the Canadian and American Courts, in Trial and Administrative Courts, and the Courts of Appeal of various American and Canadian jurisdictions, the Federal Court of Canada, and the Supreme Court of Canada. Tony Merchant, Q.C., has a long history in pursuing public policy cases and is a former Member of the Legislative Assembly (M.L.A.)